May 3, 2021

63% of US Infectious Disease Physicians Surveyed Remain Confident in Adenovirus Vector Vaccines Despite J&J Vaccine Pause, While Delaying Return to Normal Estimate in New Apollo Intelligence Report

WATERTOWN, Mass.–(BUSINESS WIRE)–Most US infectious disease doctors -63%- are confident in prescribing adenovirus COVID-19 vaccines despite J&J’s pause, says Apollo Intelligence data.


Leave Comment


Your Name *
Your Email *
Your Website
Comment *